Literature DB >> 18624921

Identification and characterization of a novel, shorter isoform of the small conductance Ca2+ -activated K+ channel SK2.

Saravana R K Murthy1, Georgeta Teodorescu, Ingrid M Nijholt, Amalia M Dolga, Stephan Grissmer, Joachim Spiess, Thomas Blank.   

Abstract

Throughout the CNS, small conductance Ca(2+)-activated potassium (SK) channels modulate firing frequency and neuronal excitability. We have identified a novel, shorter isoform of standard SK2 (SK2-std) in mouse brain which we named SK2-sh. SK2-sh is alternatively spliced at exon 3 and therefore lacks 140 amino acids, which include transmembrane domains S3, S4 and S5, compared with SK2-std. Western blot analysis of mouse hippocampal tissue revealed a 47 kDa protein product as predicted for SK2-sh along with a 64 kDa band representing the standard SK2 isoform. Electrophysiological recordings from transiently expressed SK2-sh revealed no functional channel activity or interaction with SK2-std. With the help of real-time PCR, we found significantly higher expression levels of SK2-sh mRNA in cortical tissue from AD cases when compared with age-matched controls. A similar increase in SK2-sh expression was induced in cortical neurons from mice by cytokine exposure. Substantial clinical evidence suggests that excess cytokines are centrally involved in the pathogenesis of Alzheimer's disease. Thus, SK2-sh as a downstream target of cytokines, provide a promising target for additional investigation regarding potential therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624921     DOI: 10.1111/j.1471-4159.2008.05557.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.

Authors:  Jenny Lam; Nichole Coleman; April Lourdes A Garing; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

2.  Cardiac small conductance Ca2+-activated K+ channel subunits form heteromultimers via the coiled-coil domains in the C termini of the channels.

Authors:  Dipika Tuteja; Sassan Rafizadeh; Valeriy Timofeyev; Shuyun Wang; Zheng Zhang; Ning Li; Robertino K Mateo; Anil Singapuri; J Nilas Young; Anne A Knowlton; Nipavan Chiamvimonvat
Journal:  Circ Res       Date:  2010-08-05       Impact factor: 17.367

3.  Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system.

Authors:  Ray W Turner; Mirna Kruskic; Michelle Teves; Teresa Scheidl-Yee; Shahid Hameed; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2014-05-06       Impact factor: 3.657

Review 4.  K(Ca)2 channels: novel therapeutic targets for treating alcohol withdrawal and escalation of alcohol consumption.

Authors:  Patrick J Mulholland
Journal:  Alcohol       Date:  2012-03-30       Impact factor: 2.405

5.  Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model.

Authors:  Susumu Ohya; Erina Nakamura; Sayuri Horiba; Hiroaki Kito; Miki Matsui; Hisao Yamamura; Yuji Imaizumi
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

6.  K(Ca)2 and k(ca)3 channels in learning and memory processes, and neurodegeneration.

Authors:  Els F E Kuiper; Ad Nelemans; Paul Luiten; Ingrid Nijholt; Amalia Dolga; Uli Eisel
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

7.  Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain.

Authors:  Michael Willis; Maria Trieb; Irmgard Leitner; Georg Wietzorrek; Josef Marksteiner; Hans-Günther Knaus
Journal:  Brain Struct Funct       Date:  2016-06-29       Impact factor: 3.270

Review 8.  Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.

Authors:  Deepanjali Dwivedi; Upinder S Bhalla
Journal:  Front Mol Neurosci       Date:  2021-06-03       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.